Answers are grounded in this paper and cite their sources.
This narrative review characterizes androgenetic alopecia in transgender individuals, suggesting an individualized management approach.
AGA should be regarded as a clinically significant condition in TGD individuals rather than a purely cosmetic concern. Management requires an individualized, goal-oriented, and gender-affirming approach, with oral minoxidil representing a cornerstone of therapy. Given the limited high-quality evidence, further prospective studies are needed to define optimal treatment algorithms and long-term outcomes in this population.
No takes yet. Share an insight, caveat, or question.
Ramos-Rodríguez et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: